The market is driven by the inclusion in national immunization plan, strategic alliances for Japanese encephalitis vaccines development, and the growing number of awareness campaigns
1h Free Analyst Time
The japanese encephalitis vaccines market is forecasted to grow by USD 75.69 mn during 2023-2028, accelerating at a CAGR of 6.29% during the forecast period. The report on the japanese encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by inclusion of japanese encephalitis vaccines in national immunization plan, strategic alliances for japanese encephalitis vaccine development, and growing number of awareness campaigns regarding japanese encephalitis.
The japanese encephalitis vaccines market is segmented as below:
By Type
- Inactivated vaccines
- Recombinant vaccines
- Live attenuated vaccines
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- Asia
- Europe
- North America
- Rest of World (ROW)
The report on the japanese encephalitis vaccines market covers the following areas:
- Japanese encephalitis vaccines market sizing
- Japanese encephalitis vaccines market forecast
- Japanese encephalitis vaccines market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the japanese encephalitis vaccines market: Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., Medigen Inc., Meiji Holdings Co. Ltd., Panacea Biotec Ltd., Sanofi SA, and Shandong Hengye Biotechnology Co. Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is developments of novel japanese encephalitis vaccine technology.'
According to the report, one of the major drivers for this market is the inclusion of japanese encephalitis vaccines in national immunization plan.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adimmune Corp.
- Bharat Biotech Ltd.
- Biological E. Ltd.
- Medigen Inc.
- Meiji Holdings Co. Ltd.
- Panacea Biotec Ltd.
- Sanofi SA
- Shandong Hengye Biotechnology Co. Ltd.
